The impact of medicalization and pharmaceuticalization on the quality of life of the vulnerable population

Abstract

Access to medical services is one of the benchmarks for assessing the quality of life of the population. Due to the major role of the pharmaceutical industry, there is a need to assess the influence of medicalization and pharmaceuticalization on the quality of life of vulnerable sections of the population. Focusing policies on ensuring the socio-economic security of the population is the fundamental source for improving the health of the vulnerable population

    Similar works